Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001411726-08-000005
Filing Date
2008-01-29
Accepted
2008-01-29 18:50:49
Documents
1
Period of Report
2008-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3831
  Complete submission text file 0001411726-08-000005.txt   6033
Mailing Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705
Business Address 2850 TELEGRAPH AVENUE SUITE 310 BERKELEY CA 94705 (510) 281-7700
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019 2125544284
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-55166 | Film No.: 08559375